Your weekly roundup of the latest news from Drug Topics®.
Although investigators found a lack of strong evidence to support CGM programs in community pharmacy settings, studies in ambulatory care settings suggest that these programs are both feasible and beneficial.
A recent systematic review found no serious adverse events related to the use of cannabis for the management of cancer-related symptoms in children.
Filling prescriptions for animals is essentially the same as filling prescriptions for humans—with some key differences.
LIB Therapeutics released data from the LIBerate-HeFH trial that showed lerodalcibep achieved statistically significant placebo adjusted reductions in mean LDL-C at Week 24 and at the mean of Weeks 22 and 24.
Sometimes, breaches in information are the result of a simple mistake. How can those be avoided?
Q&A: NCPA Announces Independent Community Pharmacy Consortium for Government Engagement
January 21st 2025Kurt Proctor, BS Pharm, PhD, CCHS, President of the NCPA Innovation Center, discussed his organization’s efforts in launching the Independent Community Pharmacy Consortium for Government Engagement.